Author:
Reni Michele,Zanon Silvia,Peretti Umberto,Chiaravalli Marta,Barone Diletta,Pircher Chiara,Balzano Gianpaolo,Macchini Marina,Romi Silvia,Gritti Elena,Mazza Elena,Nicoletti Roberto,Doglioni Claudio,Falconi Massimo,Gianni Luca
Subject
Gastroenterology,Hepatology
Reference18 articles.
1. Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial;Reni;Lancet Oncol,2005
2. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer;Conroy;N Engl J Med,2011
3. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine;Von Hoff;N Engl J Med,2013
4. A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel (PEXG or PDXG regimen);Reni;Cancer Chemother Pharmacol,2012
5. Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts;Sawada;Clin Cancer Res,1998
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献